Verity Pharmaceuticals   Report issue

For profit Phase 3
Founded: Toronto Canada (2016)
Status: No NME R&D (2016)

Organization Overview

First Clinical Trial
2020
NCT04439045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

VERITY | Verity Pharmaceuticals | Verity Pharmaceuticals Inc.

Active Ingredients

Marketed Drugs (1)

triptorelin (Trelstar) (2000)

Drugs in Phase 3 Trials (1)

bacille calmette-guerin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Communicable Diseases (Phase 3)

Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1